Work

Phase I study of vorinostat (suberoylanilide hydroxamic acid, NSC 701852) in combination with docetaxel in patients with advanced and relapsed solid malignancies

Year: 2010

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-010-9503-6

Authors: Bryan J. Schneider, Gregory P. Kalemkerian, Deborah Bradley, David C. Smith, Merrill J. Egorin, Stephanie Daignault, Rodney Dunn, Maha Hussain

Institutions: Weill Cornell Medicine, University of Michigan, Duke University, UPMC Hillman Cancer Center, U-M Rogel Cancer Center, Michigan Medicine

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2087834240

FWCI: 2.598

Cites: 58

Cited by: 71

Related to: 10